World Health Organisation (WHO)
The ISN is a non-state actor (NSA) in official relations with the World Health Organization (WHO): this means that the ISN has a Collaboration Plan – running from 2021-2023 -with the WHO and will cooperate with it to deliver six research and advocacy-related projects to address the global burden of kidney diseases within the context of global, regional, and national noncommunicable disease (NCD) strategies.
As part of the previous Collaboration Plan 2018-2020, the ISN developed, alongside the WHO, The ISN Framework for Developing Dialysis Programs in Low-resource Settings which outlines the requirements and operational considerations for setting up or expanding dialysis programs in resource-constrained settings and is intended as a guide to support WHO member states in developing sustainable strategies for the treatment of patients with kidney failure.
As an NSA, the ISN can attend the WHO’s World Health Assemblies and the Executive Board meetings.
Read more about our advocacy activities at the WHO here.